PCOS Blood Test Results Explained: What Your Numbers Actually Mean

You finally have results in hand. Maybe you waited two weeks for them, Googled every marker on the requisition form before the blood draw, and refreshed your patient portal a dozen times. Now you're staring at a page of flagged values and reference ranges that seem to contradict everything your symptoms are telling you.

This is one of the most common experiences women with suspected PCOS describe — and one of the most under-addressed gaps in routine care. A lab printout can confirm elevated androgens or flag your fasting insulin, but what it cannot do is translate those numbers into clinical meaning without context. That's what this article is for.

PCOS blood test results measure hormonal, metabolic, and reproductive markers that together paint a picture of how polycystic ovary syndrome is affecting your body. No single value confirms or rules out the diagnosis — interpretation depends on the full panel read together, your symptoms, and ideally, a clinician experienced in metabolic-hormonal disorders.

Here's how to understand every number on that page.

There's No Single "PCOS Test" — Here's Why That Matters

PCOS is classified as a syndrome — a cluster of signs and symptoms sharing a common biological mechanism — rather than a disease with one measurable biomarker. Diagnosis is based on the Rotterdam Criteria, established in 2003 by a joint ESHRE/ASRM consensus panel, which requires at least two of three findings: irregular or absent ovulatory cycles, clinical or biochemical evidence of excess androgens, and/or polycystic ovarian morphology on ultrasound.

Blood tests are the primary tool to establish biochemical hyperandrogenism — the androgen excess piece — and to assess the metabolic burden that frequently accompanies it. The 2018 International Evidence-Based Guideline for PCOS (Teede et al.) recommends a structured panel that encompasses androgens, reproductive hormones, and metabolic markers as standard of care.

A complete PCOS diagnostic and monitoring panel typically includes:

• Androgens: Total testosterone, free testosterone, DHEA-S, androstenedione
• Reproductive hormones: LH, FSH, LH:FSH ratio, estradiol, prolactin, progesterone
• Metabolic markers: Fasting insulin, fasting glucose, HOMA-IR, HbA1c, full lipid panel
• Thyroid function: TSH, Free T3, Free T4 (to rule out thyroid-driven mimics)
• Additional: AMH (anti-Müllerian hormone), SHBG, Vitamin D

Not every clinician orders this full panel on the first visit. If yours didn't, that's worth a follow-up conversation — incomplete testing is one reason PCOS remains undiagnosed in an estimated 70% of affected women worldwide.

High Androgens in PCOS: Understanding Your Testosterone and DHEA-S Results

Androgen excess is the most clinically defining feature of PCOS, present in roughly 60–80% of diagnosed cases. The Androgen Excess and PCOS Society has long argued that biochemical hyperandrogenism should be considered central to the disorder's definition, not just a supporting criterion.

Total Testosterone

In adult women, total testosterone typically falls between 15–70 ng/dL, though this range varies slightly by lab methodology and assay type. A result above 70 ng/dL is generally flagged as elevated, and values above 150–200 ng/dL warrant investigation for androgen-secreting tumors before PCOS is assigned as the cause.

The clinically important nuance: many women with confirmed PCOS have total testosterone that falls within the reference range. Borderline results (60–80 ng/dL) deserve attention, particularly if symptoms like hirsutism, androgenic alopecia, or cystic acne are present. Symptoms are not artifacts — they reflect androgen activity at the tissue level, which total testosterone alone doesn't fully capture.

Free Testosterone — Often the More Telling Number

Free testosterone represents the biologically active fraction not bound to sex hormone binding globulin (SHBG) or albumin. In most cases, it's a more clinically meaningful value than total testosterone for assessing androgenic activity.

The mechanism matters here. SHBG is a carrier protein produced by the liver; it binds testosterone and renders it hormonally inactive. Women with PCOS, particularly those with insulin resistance, tend to have suppressed SHBG — meaning a larger proportion of total testosterone remains free and active. The result: normal total testosterone with low SHBG can still produce significant androgenic effects, explaining why some women have symptoms despite "normal" lab values.

If your panel only measured total testosterone and didn't include SHBG and free testosterone, the full picture hasn't been assessed.

DHEA-S (Dehydroepiandrosterone Sulfate)

DHEA-S is the primary androgen produced by the adrenal glands, and its reference range in women is approximately 35–430 µg/dL (age-dependent — it declines naturally after the mid-20s). Elevated DHEA-S, particularly when testosterone is also elevated, suggests adrenal involvement in androgen excess — sometimes called "adrenal PCOS" — versus the more common ovarian-driven pattern.

Markedly elevated DHEA-S (above 700 µg/dL) warrants evaluation for adrenal hyperplasia or other adrenal pathology, as this falls outside the typical PCOS range.

Androstenedione

Less commonly included in standard panels, androstenedione is a precursor to both testosterone and estrogen produced by both the ovaries and adrenals. It's occasionally measured when other androgen values are normal but symptoms remain strongly suggestive of androgen excess, offering an additional layer of diagnostic sensitivity.

LH, FSH, and the LH:FSH Ratio — What the Ratio Really Tells You

LH and FSH

Luteinizing hormone (LH) drives ovulation and stimulates ovarian androgen production. Follicle-stimulating hormone (FSH) promotes follicle development. In a typical menstrual cycle, these hormones rise and fall in a coordinated rhythm.

In PCOS, this rhythm is frequently disrupted. The hypothalamic-pituitary axis secretes LH at an elevated baseline, while FSH remains relatively suppressed. This creates the elevated LH with normal-to-low FSH pattern classically associated with the condition, and it's one of the reasons ovulation either doesn't occur or occurs irregularly — FSH isn't rising sufficiently to mature a dominant follicle.

An LH:FSH ratio of 2:1 or 3:1 is considered a soft marker for PCOS. It's not included in formal diagnostic criteria (Rotterdam doesn't require it), but it adds supporting evidence to the clinical picture.

Critical caveat: LH levels fluctuate significantly with cycle phase, stress, and even time of day. A single measurement is rarely definitive. Results are most interpretable when drawn during the early follicular phase (cycle days 2–5) if menstrual cycles are occurring.

Estradiol

Estradiol (E2) levels in PCOS are typically normal to mildly elevated in the follicular phase, though chronic anovulation can skew results significantly depending on when the blood was drawn. Because follicular development stalls without adequate FSH, women with PCOS often have multiple developing but non-dominant follicles — each producing estrogen — which can push estradiol slightly higher than expected.

Interpretation requires knowing cycle timing. An estradiol result without that context is difficult to assess precisely.

Prolactin

Prolactin is included in PCOS panels primarily as a rule-out, not a diagnostic marker. Hyperprolactinemia (elevated prolactin) can independently cause irregular cycles and occasionally presents with androgen-like symptoms, making it a clinical mimic worth excluding. Mildly elevated prolactin (up to 1.5–2× the upper reference limit) warrants a repeat fasting morning measurement before further investigation, as a number of factors — exercise, stress, recent meals, even a breast exam prior to the draw — can transiently elevate it.

AMH (Anti-Müllerian Hormone)

AMH has emerged as an increasingly useful biomarker in PCOS assessment. Produced by small antral follicles, AMH is significantly elevated in PCOS due to the characteristically high follicle count seen on ovarian ultrasound. Values typically 2–3 times the normal range for age are common in PCOS and are being proposed by some researchers as a potential surrogate for the ovarian morphology criterion.

Normal AMH in reproductive-age women generally falls between 1.0–3.5 ng/mL, with PCOS-associated values often exceeding 4–5 ng/mL and sometimes reaching 10+ ng/mL. However, AMH assays are not yet standardized across labs, meaning the same blood sample can yield different numeric results depending on where it's processed. Trend values (following AMH over time with the same lab) are more meaningful than any single cross-sectional result.

Insulin Resistance Labs Explained — Fasting Insulin, HOMA-IR, HbA1c, and More

This is where the metabolic dimension of PCOS gets underexplored in many clinical encounters — and where the consequences of incomplete testing are most significant. Insulin resistance affects an estimated 70–80% of women with PCOS, including lean women with normal BMI. It amplifies androgen production, disrupts ovulation, and substantially increases long-term cardiometabolic risk, including a threefold elevated risk of developing type 2 diabetes.

Fasting Insulin

Fasting insulin is not a standard component of a basic metabolic panel — it must be specifically ordered. The omission is common and consequential.

Standard lab reference ranges often flag fasting insulin as abnormal only above 20–25 µIU/mL. But clinically, many practitioners specializing in metabolic health consider values above 10–12 µIU/mL to be functionally elevated, particularly when paired with symptoms of insulin resistance (fatigue after meals, carbohydrate cravings, central weight accumulation, acanthosis nigricans). This disconnect between lab-normal and clinically meaningful drives much of the "your results are fine" experience that leaves women undiagnosed for years.

Fasting Glucose

The standard threshold for prediabetes begins at 100 mg/dL (fasting), and type 2 diabetes at 126 mg/dL or above. However, fasting glucose alone has poor sensitivity for early insulin resistance — the pancreas can compensate for years by secreting more insulin, keeping glucose within range even as insulin sensitivity declines significantly. Fasting glucose without fasting insulin misses the compensatory hyperinsulinemia that is the hallmark of early metabolic dysfunction in PCOS.

HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)

HOMA-IR is calculated from fasting insulin and fasting glucose using this formula:

HOMA-IR = (Fasting Insulin [µIU/mL] × Fasting Glucose [mg/dL]) ÷ 405

Developed by Matthews et al. (1985) at Oxford, it remains one of the most widely validated surrogate measures of insulin sensitivity in research and clinical settings. Broadly accepted thresholds:

• HOMA-IR < 1.5: Optimal insulin sensitivity
• HOMA-IR 1.5–2.0: Mild reduction in sensitivity
• HOMA-IR > 2.0: Insulin resistance; clinically meaningful
• HOMA-IR > 3.0: Significant resistance; warrants active intervention

HOMA-IR isn't always calculated or reported by labs. If your results include fasting insulin and fasting glucose, you can compute it yourself using the formula above — and bring that number to your appointment as a discussion point.

HbA1c

Hemoglobin A1c reflects average blood glucose over the preceding 8–12 weeks by measuring glucose attachment to red blood cells. It's a valuable long-term marker, but it detects glycemic dysregulation rather than insulin resistance itself. Normal is below 5.7%; prediabetes is 5.7–6.4%; diabetes is 6.5% or above.

In PCOS, HbA1c is most useful for monitoring metabolic trajectory over time, particularly after interventions, rather than initial diagnosis of insulin resistance.

Lipid Panel in PCOS

The dyslipidemia pattern in PCOS has a characteristic fingerprint: elevated triglycerides, reduced HDL cholesterol, and elevated small-dense LDL particles — the most atherogenic LDL subtype. Standard lipid panels report total LDL, which can appear only mildly elevated even when particle quality is poor. This is a meaningful risk: women with PCOS carry elevated cardiovascular risk independent of weight, and lipid quality matters as much as quantity. To learn more about managing this specific risk, see Meto's overview of dyslipidemia.

TSH and Thyroid Tests: Why Your Doctor Checks These Alongside PCOS Labs

Hypothyroidism — particularly Hashimoto's thyroiditis, the autoimmune form — can closely mimic PCOS: irregular or absent periods, weight gain, fatigue, mood changes, and sometimes hair loss. The two conditions also co-occur at rates higher than chance, making thyroid function a non-negotiable component of a thorough hormonal workup.

TSH (thyroid-stimulating hormone) is the standard screening marker, with a reference range of approximately 0.5–4.5 mIU/L in most labs. Values above 4.5 mIU/L suggest primary hypothyroidism; values below 0.5 mIU/L suggest hyperthyroidism or excessive thyroid hormone replacement.

Free T3 and Free T4 provide additional granularity: Free T4 reflects thyroid hormone output; Free T3 (the active form) reflects peripheral conversion, which can be impaired in metabolic dysfunction even when TSH is normal.

Thyroid antibodies (anti-TPO and anti-thyroglobulin) are added when Hashimoto's is suspected — they can be elevated years before TSH becomes abnormal and confirm autoimmune thyroid disease as the underlying driver of symptoms.

PCOS Lab Results at a Glance — Reference Ranges and What They Mean

Note: Reference ranges vary by laboratory method and analyzer. The values below are broadly representative; always interpret results in context with your clinical presentation and the specific reference ranges provided by your lab.

Why Your Results Can Look Normal — and You Can Still Have PCOS

This might be the most important section in this article for women who've been told their labs are "fine" while their symptoms remain very much not.

Phenotypic diversity is real. PCOS presents across at least four recognized phenotypes based on which Rotterdam criteria are met. Women with phenotype D (irregular cycles + polycystic ovaries, without biochemical androgen excess) may have entirely normal testosterone and DHEA-S values — and still legitimately meet PCOS criteria.

Lean PCOS is a documented clinical reality. Women with a normal BMI and PCOS frequently have milder biochemical findings but can carry the same degree of insulin resistance and metabolic risk as their higher-weight counterparts. Research from Dunaif et al. established that insulin resistance in PCOS is a primary intrinsic defect — not secondary to adiposity — meaning you cannot rule it out based on weight alone.

Standard lab ranges are population averages, not clinical thresholds. A fasting insulin of 18 µIU/mL falls within many labs' reference range but represents a level associated with significant insulin resistance in clinical research. The lab doesn't know your symptoms; it reports a number against a population mean. Your clinician's interpretation — shaped by the full picture — is what matters.

Cycle timing matters. Results drawn at the wrong cycle phase can appear falsely reassuring or falsely abnormal. LH in the mid-cycle surge looks very different from LH on day 3. If your draw wasn't timed intentionally, the values may be less informative than they appear.

10 Questions to Ask Your Doctor When Reviewing Your PCOS Blood Results

Bring these to your next appointment. They're not confrontational — they're clinically appropriate:

1. Was my full androgen panel tested, including free testosterone and SHBG — not just total testosterone?
2. Was HOMA-IR calculated from my fasting insulin and glucose, or was only fasting glucose ordered?
3. What does my AMH level suggest about my antral follicle count and ovarian function?
4. Were thyroid antibodies (anti-TPO) included, or just TSH?
5. Were my samples drawn at a consistent time of day and cycle phase?
6. Do my results suggest a predominant phenotype — androgen-driven, metabolic, or mixed?
7. What cardiovascular and metabolic risk does my current lipid pattern carry?
8. Are there follow-up tests or repeat intervals recommended given these results?
9. What lifestyle or nutritional interventions are most supported by my specific metabolic markers?
10. Are there medical treatments — insulin sensitizers, anti-androgens — that my results support considering?

How Meto Approaches PCOS Blood Testing Differently

Most women with PCOS spend years in a cycle of partial answers. A routine ob-gyn visit yields a testosterone level and a prescription for oral contraceptives. The metabolic layer goes untested. The root-cause driver — whether it's androgen excess, insulin resistance, or both — never gets properly characterized. And so the management remains symptomatic rather than mechanistic.

At Meto, the clinical position is that PCOS cannot be adequately managed without a complete metabolic and hormonal characterization upfront. The PCOS & Hormonal Health Panel tests the full suite of relevant biomarkers: total and free testosterone, DHEA-S, LH, FSH, estradiol, progesterone, SHBG, TSH, and fasting insulin — the markers most clinicians agree are necessary but rarely order together in a single visit.

More critically, Meto pairs lab results with clinician review rather than sending patients to interpret flagged values alone. Every panel comes with a personalized hormonal and metabolic report and direct access to a clinician who specializes in conditions like insulin resistance, metabolic syndrome, and PCOS — not a generalist managing the condition alongside a hundred other concerns.

The Meto approach is grounded in a simple clinical principle: you cannot treat what you haven't measured, and you cannot personalize care built on incomplete data.

For women dealing with stubborn weight resistance, hormonal acne, irregular cycles, or infertility concerns — conditions that frequently co-exist in PCOS — the path to meaningful management starts with knowing exactly what your biology is doing, not approximating it.

Get Your Own PCOS Panel — Complete Answers, Not Partial Ones

If you've been waiting for clear answers, or if your previous labs left more questions than they answered, Meto's PCOS & Hormonal Health Panel is built for exactly this situation.

The panel includes: Total & Free Testosterone · DHEA-S · LH & FSH · Estradiol · Progesterone · SHBG · TSH · Fasting Insulin

What you get: Results within 3–5 days, a personalized hormonal and metabolic report, and a clinician review with clear, actionable next-step recommendations.

→ Order Your PCOS Panel at Meto

Next Steps After Your PCOS Lab Results — From Diagnosis to Management

What happens after the bloodwork depends heavily on what the results show — and results in PCOS rarely point in a single direction.

If PCOS is confirmed: The next clinical priority is phenotyping — identifying which biological drivers are most active in your case. Androgen-dominant PCOS and insulin-resistant PCOS, while often overlapping, benefit from partially different management approaches. Anti-androgen therapy (spironolactone), insulin sensitizers (metformin, inositol), cycle regulation, and targeted nutritional strategies each have different evidence bases depending on your specific lab profile.

If results are borderline: Repeat testing — particularly for testosterone and fasting insulin — is often appropriate. Single measurements have inherent biological variability. A 3–6 month retest after lifestyle modification can also reveal whether metabolic markers are responsive to intervention, itself a clinically useful data point.

If results are normal but symptoms persist: This warrants subspecialty evaluation rather than dismissal. The phenotypic breadth of PCOS, combined with the limitations of standard reference ranges, means normal biochemistry doesn't automatically rule out the syndrome when two other Rotterdam criteria are clearly met.

Tracking your labs over time is as important as any individual result. Fasting insulin and HOMA-IR are particularly sensitive to lifestyle, dietary, and pharmacological intervention — they can shift meaningfully within months and serve as useful signals that a management approach is working (or isn't).

Your Labs Are a Starting Point, Not a Verdict

A positive PCOS panel is not a life sentence. It's clinical information — the kind that finally gives you something concrete to work with after what may have been years of vague answers and dismissed symptoms.

Elevated testosterone explains the acne. High fasting insulin explains the weight that doesn't respond to standard dietary approaches. A disrupted LH:FSH ratio explains the cycle irregularity that's been brushed off as "just stress." Individually, these values are numbers. Together, read in clinical context, they're a map — one that points toward root causes rather than surface-level symptom management.

Bring this article to your next appointment. Use the reference table. Ask the ten questions. And if your current care isn't giving you the depth of evaluation your symptoms warrant, know that the option for more comprehensive testing and clinician-guided interpretation exists.

This article is intended for educational purposes and does not constitute medical advice. PCOS diagnosis and management should be conducted in partnership with a qualified healthcare provider. If you have concerns about your symptoms or lab results, consult a clinician experienced in metabolic and hormonal health.